Simultaneous depletion of TAMs with zoledronic acid and treatment with sorafenib inhibited primary tumor growth and lung metastasis in an orthotopic HCC model through the reduction of the CXCR4+ vascular density [262]. The gene discussed is CXCR4; the disease is neoplasm.